• market

  PRIVATE

• industry

  Pharmaceuticals

• website

  phosplatin.com

• crunchbase

  phosplatin-therapeutics

Promontory Therapeutics Inc. is a clinical stage pharmaceutical company focused on developing small molecule immunotherapies for oncology. The company's lead candidate, PT-112, exhibits a unique combination of properties, including immunogenic cell death and osteotropism, providing advantages in dealing with cancers that originate in or metastasize to the bone.